255 related articles for article (PubMed ID: 25853443)
1. Incidence and indications for pars plana vitrectomy following the treatment of posterior uveal melanomas in Scotland.
Chia SN; Smith HB; Hammer HM; Kemp EG
Eye (Lond); 2015 Jun; 29(6):748-56. PubMed ID: 25853443
[TBL] [Abstract][Full Text] [Related]
2. Pars plana vitrectomy to repair retinal detachment following brachytherapy for uveal melanoma.
Beykin G; Pe'er J; Hemo Y; Frenkel S; Chowers I
Br J Ophthalmol; 2013 Dec; 97(12):1534-7. PubMed ID: 24064939
[TBL] [Abstract][Full Text] [Related]
3. Vitreous hemorrhage after plaque radiotherapy for uveal melanoma.
Bianciotto C; Shields CL; Pirondini C; Mashayekhi A; Furuta M; Shields JA
Retina; 2012 Jun; 32(6):1156-64. PubMed ID: 22366905
[TBL] [Abstract][Full Text] [Related]
4. Role of vitreoretinal surgery in maximizing treatment outcome following complications after proton therapy for uveal melanoma.
Tran BK; Schalenbourg A; Bovey E; Zografos L; Wolfensberger TJ
Retina; 2013 Oct; 33(9):1777-83. PubMed ID: 23792487
[TBL] [Abstract][Full Text] [Related]
5. Transscleral local resection versus iodine brachytherapy for uveal melanomas that are large because of tumour height.
Puusaari I; Damato B; Kivelä T
Graefes Arch Clin Exp Ophthalmol; 2007 Apr; 245(4):522-33. PubMed ID: 17111148
[TBL] [Abstract][Full Text] [Related]
6. Neoadjuvant proton beam irradiation vs. adjuvant ruthenium brachytherapy in transscleral resection of uveal melanoma.
Böker A; Pilger D; Cordini D; Seibel I; Riechardt AI; Joussen AM; Bechrakis NE
Graefes Arch Clin Exp Ophthalmol; 2018 Sep; 256(9):1767-1775. PubMed ID: 29907945
[TBL] [Abstract][Full Text] [Related]
7. Pars plana vitrectomy in eyes containing a treated posterior uveal melanoma.
Foster WJ; Harbour JW; Holekamp NM; Shah GK; Thomas MA
Am J Ophthalmol; 2003 Sep; 136(3):471-6. PubMed ID: 12967800
[TBL] [Abstract][Full Text] [Related]
8. Endoresection with adjuvant ruthenium brachytherapy for selected uveal melanoma patients - the Tuebingen experience.
Süsskind D; Dürr C; Paulsen F; Kaulich T; Bartz-Schmidt KU
Acta Ophthalmol; 2017 Dec; 95(8):e727-e733. PubMed ID: 27914117
[TBL] [Abstract][Full Text] [Related]
9. 23-mm iodine-125 plaque for uveal melanoma: benefit of vitrectomy and silicone oil on visual acuity.
McCannel TA; Kamrava M; Demanes J; Lamb J; Bartlett JD; Almanzor R; Chun M; McCannel CA
Graefes Arch Clin Exp Ophthalmol; 2016 Dec; 254(12):2461-2467. PubMed ID: 27638702
[TBL] [Abstract][Full Text] [Related]
10. Safety of pars plana vitrectomy in eyes with plaque-irradiated posterior uveal melanoma.
Bansal AS; Bianciotto CG; Maguire JI; Regillo CD; Shields JA; Shields CL
Arch Ophthalmol; 2012 Oct; 130(10):1285-90. PubMed ID: 23044941
[TBL] [Abstract][Full Text] [Related]
11. [Therapy of radiation resistant malignant uveal melanoma with endoresection by pars plana vitrectomy in two patients].
Schmidt JC; Brieden-Azvedo S; Nietgen GW
Klin Monbl Augenheilkd; 2001 Dec; 218(12):800-4. PubMed ID: 11805872
[TBL] [Abstract][Full Text] [Related]
12. Management of exudative retinal detachment in choroidal melanoma.
Gibran SK; Kapoor KG
Clin Exp Ophthalmol; 2009 Sep; 37(7):654-9. PubMed ID: 19788660
[TBL] [Abstract][Full Text] [Related]
13. [Endoresection following proton beam irradiation of large uveal melanomas].
Bechrakis NE; Höcht S; Martus P; Kreusel KM; Heese J; Foerster MH
Ophthalmologe; 2004 Apr; 101(4):370-6. PubMed ID: 15067418
[TBL] [Abstract][Full Text] [Related]
14. Endoresection utilizing pars plana vitrectomy for benign and malignant intraocular tumors.
Reichstein D; Karan K
Curr Opin Ophthalmol; 2019 May; 30(3):151-158. PubMed ID: 30883440
[TBL] [Abstract][Full Text] [Related]
15. Ruthenium-106 plaque brachytherapy for uveal melanoma.
Tarmann L; Wackernagel W; Avian A; Mayer C; Schneider M; Winkler P; Langmann G
Br J Ophthalmol; 2015 Dec; 99(12):1644-9. PubMed ID: 25979763
[TBL] [Abstract][Full Text] [Related]
16. Tumor parameters predict the risk of side effects after ruthenium-106 plaque brachytherapy of uveal melanomas.
Tarmann L; Wackernagel W; Ivastinovic D; Schneider M; Winkler P; Langmann G
PLoS One; 2017; 12(8):e0183833. PubMed ID: 28859118
[TBL] [Abstract][Full Text] [Related]
17. Comment on: 'Pars plana vitrectomy to repair retinal detachment following brachytherapy for uveal melanoma'.
Chia SN; Smith HB; Kemp EG
Br J Ophthalmol; 2014 Apr; 98(4):571. PubMed ID: 24390168
[No Abstract] [Full Text] [Related]
18. Outcomes of treatment with stereotactic radiosurgery or proton beam therapy for choroidal melanoma.
Sikuade MJ; Salvi S; Rundle PA; Errington DG; Kacperek A; Rennie IG
Eye (Lond); 2015 Sep; 29(9):1194-8. PubMed ID: 26160531
[TBL] [Abstract][Full Text] [Related]
19. Plaque brachytherapy for posterior uveal melanoma in 2018: improved techniques and expanded indications.
Reichstein D; Karan K
Curr Opin Ophthalmol; 2018 May; 29(3):191-198. PubMed ID: 29538180
[TBL] [Abstract][Full Text] [Related]
20. Auditing outcomes after treatment of Scottish patients with uveal melanoma in Liverpool.
Wright PK; Damato BE
J R Coll Surg Edinb; 1999 Aug; 44(4):260-4. PubMed ID: 10453150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
